I-STEP: Increasing Screening Through Engaging Primary Care Providers
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer Screening
- Sponsor
- Washington University School of Medicine
- Enrollment
- 193
- Locations
- 7
- Primary Endpoint
- Number of initial low-dose CT (LDCT) scan screenings per month per screening center
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.
Investigators
Eligibility Criteria
Inclusion Criteria
- •To be eligible to participate in the trial, screening centers have to be existing members of the BJC Collaborative.
- •Primary Care Providers have to have a referral relationship with the screening center; serve adult patients who may be screening-eligible, and are willing to interact with the referral site to implement referral for LDCT.
Exclusion Criteria
- •There are not any exclusion criteria for the study
Outcomes
Primary Outcomes
Number of initial low-dose CT (LDCT) scan screenings per month per screening center
Time Frame: Completion of study (estimated to be 21 months)
-Screening will be defined as completed initial screen for lung cancer
Secondary Outcomes
- Number of primary care providers who refer at least two patients per month for LDCT(Completion of study (estimated to be 21 months))
- Percent of patients referred who are screen-eligible(Completion of study (estimated to be 21 months))
- Percent of patients referred who complete screening(Completion of study (estimated to be 21 months))